No abstract available
Keywords:
carfilzomib; mantle cell lymphoma; proteasome inhibition; refractory lymphoma; relapsed lymphoma.
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Aged
-
Disease-Free Survival
-
Female
-
Humans
-
Lymphoma, Mantle-Cell / drug therapy*
-
Lymphoma, Mantle-Cell / mortality
-
Male
-
Middle Aged
-
Oligopeptides / administration & dosage*
-
Oligopeptides / adverse effects
-
Prospective Studies
-
Survival Rate
Substances
-
Oligopeptides
-
carfilzomib